...
首页> 外文期刊>Planta medica: Natural products and medicinal plant research >Effect of Oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma.
【24h】

Effect of Oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma.

机译:稻提取物对哮喘实验动物模型中气道炎症进展和重塑的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Airway inflammation and remodeling in chronic asthma are characterized by airway eosinophilia, hyperplasia of smooth muscle and goblet cells, and subepithelial fibrosis. The present study was undertaken to evaluate the effects of DA-9201, an ethanolic extract of black rice (Oryza sativa L.), on airway inflammation and remodeling in a murine model of chronic asthma. BALB/c mice sensitized to ovalbumin (OVA) were chronically challenged with aerosolized OVA for 6 weeks. DA-9201 (30, 100, or 300 mg/kg) or dexamethasone (3 mg/kg) was orally administered during the last 4 and 2 weeks, respectively. Airway inflammation, lung pathology by histomorphometry and immunohistochemistry, IgE level and Th2 cytokines were evaluated. The OVA-treated mice showed extensive eosinophilia, chronic inflammatory responses and characteristics of airway remodeling including subepithelial fibrosis, smooth muscle hypertrophy, and goblet cell hyperplasia. As compared to the OVA-treated control group, treatment with DA-9201 resultedin significant reductions in the accumulation of eosinophils in peribronchial areas, chronic pulmonary inflammation and progression of airway remodeling. Furthermore, DA-9201 significantly reduced total serum and BALF IgE levels and Th2 cytokines. These results indicate that DA-9201 may play an important role in attenuating the progressing of airway inflammation and remodeling and suggest the potential benefits of DA-9201 in prevention or treatment of asthma.
机译:慢性哮喘中的气道炎症和重塑的特征是气道嗜酸性粒细胞增多,平滑肌和杯状细胞增生以及上皮下纤维化。本研究旨在评估DA-9201(黑米(Oryza sativa L.)的乙醇提取物)对慢性哮喘小鼠模型气道炎症和重塑的影响。对卵清蛋白(OVA)致敏的BALB / c小鼠用雾化的OVA长期攻击6周。在最近4周和2周内分别口服DA-9201(30、100或300 mg / kg)或地塞米松(3 mg / kg)。评估气道炎症,通过组织形态计量学和免疫组织化学的肺病理学,IgE水平和Th2细胞因子。 OVA处理的小鼠表现出广泛的嗜酸性粒细胞增多,慢性炎症反应和气道重塑的特征,包括上皮下纤维化,平滑肌肥大和杯状细胞增生。与OVA治疗的对照组相比,DA-9201治疗显着减少了支气管周围区域嗜酸性粒细胞的积累,慢性肺部炎症和气道重塑的进展。此外,DA-9201显着降低了总血清和BALF IgE水平以及Th2细胞因子。这些结果表明,DA-9201在减轻气道炎症和重塑过程中可能起重要作用,并暗示DA-9201在预防或治疗哮喘中的潜在益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号